Ayurcann Holdings Corp.
AYURF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $6,087 | $7,745 | $7,558 | $7,502 |
| % Growth | -21.4% | 2.5% | 0.7% | – |
| Cost of Goods Sold | $4,548 | $7,072 | $4,979 | $4,231 |
| Gross Profit | $1,539 | $1,502 | $2,579 | $3,272 |
| % Margin | 25.3% | 19.4% | 34.1% | 43.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1,389 | $1,546 | $1,502 | $1,783 |
| SG&A Expenses | $2,991 | $3,109 | $2,795 | $2,969 |
| Sales & Mktg Exp. | $1,601 | $1,563 | $1,294 | $1,187 |
| Other Operating Expenses | -$765 | $73 | $170 | $224 |
| Operating Expenses | $2,226 | $3,182 | $2,966 | $3,193 |
| Operating Income | -$687 | -$1,843 | -$387 | $79 |
| % Margin | -11.3% | -23.8% | -5.1% | 1% |
| Other Income/Exp. Net | -$105 | -$92 | -$175 | -$200 |
| Pre-Tax Income | -$793 | -$2,601 | -$562 | -$122 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$793 | -$1,910 | -$562 | -$122 |
| % Margin | -13% | -24.7% | -7.4% | -1.6% |
| EPS | -0.004 | -0.01 | -0.003 | -0.001 |
| % Growth | 58.2% | -237.9% | -383.3% | – |
| EPS Diluted | -0.004 | -0.01 | -0.003 | -0.001 |
| Weighted Avg Shares Out | 194,704 | 194,704 | 194,704 | 194,704 |
| Weighted Avg Shares Out Dil | 194,704 | 194,704 | 194,704 | 194,704 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $105 | $68 | $175 | $200 |
| Depreciation & Amortization | $119 | $243 | $179 | $228 |
| EBITDA | -$569 | -$2,266 | -$208 | $318 |
| % Margin | -9.3% | -29.3% | -2.7% | 4.2% |